Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis

Leptomeningeal contrast enhancement (LMCE) on magnetic resonance imaging (MRI) is a newly recognized possible biomarker in multiple sclerosis (MS), associated with MS progression and cortical atrophy. In this study, we aimed to assess the prevalence of LMCE foci and their impact on neurodegeneration...

Descripción completa

Detalles Bibliográficos
Autores principales: Makshakov, Gleb, Magonov, Evgeniy, Totolyan, Natalia, Nazarov, Vladimir, Lapin, Sergey, Mazing, Alexandra, Verbitskaya, Elena, Trofimova, Tatiana, Krasnov, Vladimir, Shumilina, Maria, Skoromets, Alexander, Evdoshenko, Evgeniy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643086/
https://www.ncbi.nlm.nih.gov/pubmed/29291134
http://dx.doi.org/10.1155/2017/8652463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643086/
https://www.ncbi.nlm.nih.gov/pubmed/29291134
http://dx.doi.org/10.1155/2017/8652463

Ejemplares similares